About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
CHEK - Check-Cap Ltd.| Previous Close | $2.09 | Open | |
| Volume | 614.2K | Market Cap | 78.13M |
| Yield | Last Dividend |
| CHEK Stock: Check Cap Climbs On NASDAQ E... | 01/04/21 |
| CHEK stock is running for the top in the market as investors cheer a 180-day NASDAQ extension by squeezing the shorts. | |
| Global Capsule Endoscopy Market Analysis... | 11/05/20 |
| InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on ???Global Capsule Endoscopy Market Assessment ??? Revenue (US$ ... | |
| Anchor at Canada???s CHEK News hits back... | 09/10/20 |
| When Kori Sidaway received an email from a person who identified themselves as the 'Vancouver Island Cleavage Patrol', she didn't take it lightly. | |
| California Forced Into Rolling Blackouts... | 08/15/20 |
| California Forced Into Rolling Blackouts As Heatwave Sparks First "Stage 3" Energy Crisis In 20 Years Tyler Durden Sat, 08/15/2020 - 12:11 While the r... | |
| All You Need to Know About CheckCap Ltd.... | 05/22/20 |
| CheckCap Ltd. (CHEK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive ... | |
| Check-Cap Ltd. Announces $4.5 Million Re... | 04/30/20 |
| /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing ... | |
| Check-Cap Ltd. Announces $4.0 Million Re... | 04/20/20 |
| ISFIYA, Israel, April 20, 2020 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical... | |
| Check-Cap Announces Positive Results fro... | 12/30/19 |
| /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics co... | |
| Check-Cap Announces $4.75 Million Privat... | 12/20/19 |
| ISFIYA, Israel, Dec. 20, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinica... | |
| Check-Cap Reports Third Quarter 2019 Fin... | 11/06/19 |
| ISFIYA, Israel, Nov. 6, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical... | |
| Check-Cap to Present at the Dawson James... | 10/24/19 |
| ISFIYA, Israel , Oct. 24, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinic... | |
| Check-Cap Announces Final Results From P... | 07/09/19 |
| Check-Cap (NASDAQ: CHEK ) announced positive final results from its recently completed post-CE approval study evaluating the clinical performance and ... | |
| Check-Cap Announces Positive Final Resul... | 07/09/19 |
| ISFIYA, Israel, July 9, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (CHEK) (NASDAQ:CHEKW), (NASDAQ:CHEKZ), a clinical stage med... | |
| Check-Cap up 12% premarket ahead of C-Sc... | 05/16/19 |
| Thinly traded nano cap Check-Cap (CHEK) is up 12% premarket on modestly higher volume in apparent response to its announcement of an upcoming data pre... | |
| Check-Cap beats by $0.03 | 05/13/19 |
| No summary available. | |
| Curis leads healthcare gainers; Recro Ph... | 03/25/19 |
| No summary available. | |
| Check-Cap appoints new finance executive | 03/18/19 |
| No summary available. | |
| Medical devices maintain strength, IHI u... | 02/12/19 |
| No summary available. | |
| Check-Cap up 5% on receiving IRB approva... | 02/12/19 |
| No summary available. | |
| Evolus leads healthcare gainers; Fortres... | 02/04/19 |
| No summary available. | |
| AU and CHEK among premarket losers | 02/04/19 |
| No summary available. | |
| OncoCyte leads healthcare gainers; Aller... | 01/29/19 |
| No summary available. | |
| Check-Cap up 12% | 01/25/19 |
| No summary available. | |
| Avid Bioservices and Check-Cap among hea... | 01/25/19 |
| No summary available. | |
| Buy rating | 11/19/20 |
| HC Wainwright & Co. maintains Buy rating and lowers Price Target from $2.00 to $1.50 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
| R R Investments | Roland Van Rij | 39.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
